| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 02/19/2014 | CN101878022B A method for producing adapalene gels |
| 02/19/2014 | CN101677940B Composition for combating epistaxis |
| 02/18/2014 | US8653320 Deodorizing super-absorbent composition |
| 02/18/2014 | US8653286 Intermediates useful in the preparation of maleimide functionalized polymers |
| 02/18/2014 | US8653255 Sialic acid derivatives for protein derivatisation and conjugation |
| 02/18/2014 | US8653238 Compositions and methods for transport of molecules with enhanced release properties across biological barriers |
| 02/18/2014 | US8653140 Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders |
| 02/18/2014 | US8653107 Fentanyl composition for nasal administration |
| 02/18/2014 | US8653030 Pharmaceutical formulation composed of a polymer blend and an active compound for time-controlled release |
| 02/18/2014 | US8652528 Drug loaded polymeric nanoparticles and methods of making and using same |
| 02/18/2014 | US8652524 Organ regeneration device |
| 02/18/2014 | US8652517 Coating of tablet cores |
| 02/18/2014 | US8652508 Dietary formulations and methods for treatment of inflammation and other disorders |
| 02/18/2014 | US8652506 Bio-degradable block co-polymers for controlled release |
| 02/18/2014 | US8652491 Transdermal compositions for anticholinergic agents |
| 02/18/2014 | US8652487 Tolerogenic synthetic nanocarriers for inducing regulatory B cells |
| 02/18/2014 | US8652484 Delivery system for cytotoxic drugs by bispecific antibody pretargeting |
| 02/18/2014 | US8652482 HPV E6 protein T cell epitopes and uses thereof |
| 02/18/2014 | US8652479 Antibody-drug conjugates and methods |
| 02/18/2014 | US8652464 Method of treatment using nanoparticulate compositions having lysozyme as a surface stabilizer |
| 02/18/2014 | US8652456 Aqueous preparations comprising at least one water-soluble or water-dispersible copolymer with cationgenic groups |
| 02/18/2014 | US8652450 Soap-based liquid wash formulations with enhanced deposition of conditioning and/or skin appearance enhancing agents |
| 02/18/2014 | CA2674838C Anti-ige vaccines |
| 02/18/2014 | CA2637630C Process for producing lactamide compounds, new lactamide compounds and formulations containing lactamide compounds |
| 02/18/2014 | CA2634394C Homogeneous paste formulations |
| 02/18/2014 | CA2622529C Secretory cell-containing macrobeads comprising seakem gold agarose, and uses thereof |
| 02/18/2014 | CA2614312C Drug-introduced photo-crosslinked hyaluronic acid derived gel |
| 02/18/2014 | CA2587805C Improved vitamin d content uniformity in pharmaceutical dosage forms |
| 02/18/2014 | CA2564076C Chemical linkers and conjugates thereof |
| 02/18/2014 | CA2560472C Method for improved breast milk feeding to reduce the risk of allergy |
| 02/18/2014 | CA2547034C Anticarcinoma antibodies and uses thereof |
| 02/18/2014 | CA2500742C Compositions of fgf-18 and hyaluronic acid for stimulating cartilage production and treating osteoarthritis |
| 02/18/2014 | CA2496317C Method of producing hydroxyalkyl starch derivatives |
| 02/18/2014 | CA2454756C Methods and compounds for the targeting of protein to exosomes |
| 02/18/2014 | CA2451741C Peyers's patch and/or m-celle targeting ligands |
| 02/13/2014 | WO2014026143A1 Conjugated anti-microbial compounds and conjugated anti-cancer compounds and uses thereof |
| 02/13/2014 | WO2014026142A1 Methods and compostions for tissue adhesives |
| 02/13/2014 | WO2014025979A1 Compositions comprising spicamycin derivatives and methods of use thereof |
| 02/13/2014 | WO2014025890A1 Drug delivery vehicle comprising conjugates between targeting polyamino acids and fatty acids |
| 02/13/2014 | WO2014025805A1 Carbohydrate conjugated rna agents and process for their preparation |
| 02/13/2014 | WO2014025795A1 Compositions for the delivery of rna and drugs into cells |
| 02/13/2014 | WO2014025290A1 External therapy remedy for patients with atopic dermatitis |
| 02/13/2014 | WO2014025206A1 Fast-dissolving oral film preparation comprising aripiprazole |
| 02/13/2014 | WO2014025042A1 Stable oxaliplatin-encapsulating liposome aqueous dispersion and method for stabilizing same |
| 02/13/2014 | WO2014024896A1 Adhesive patch agent containing agomelatine |
| 02/13/2014 | WO2014024268A1 Medicine |
| 02/13/2014 | WO2014024193A1 Compositions and methods for rapid transmucosal delivery of pharmaceutical ingredients |
| 02/13/2014 | WO2014024189A1 Pegylated high affinity leptins with increased biological activity |
| 02/13/2014 | WO2014023816A1 Method for lowering the viscosity of high-concentration protein solutions |
| 02/13/2014 | WO2014023752A1 Interleukin-2 fusion proteins and uses thereof |
| 02/13/2014 | WO2014023679A1 Composition comprising two antibodies engineered to have reduced and increased effector function |
| 02/13/2014 | WO2014023288A1 Method for introducing biologically active substances into the brain |
| 02/13/2014 | WO2014001653A4 Monopolymer multifunctional sequenced cast polyurethane matrix and production method |
| 02/13/2014 | WO2013188864A3 Anti-cd22 anti-idiotypic antibodies and uses thereof |
| 02/13/2014 | WO2013188273A8 Topical ophthalmological pharmaceutical composition containing axitinib |
| 02/13/2014 | WO2013188268A8 Topical ophthalmological pharmaceutical composition containing pazopanib |
| 02/13/2014 | WO2013186545A3 Chaperone/usher fusion proteins |
| 02/13/2014 | US20140046287 Microfabricated nanopore device for sustained release of therapeutic agent |
| 02/13/2014 | US20140046021 Self-magnetic metal-salen complex compound |
| 02/13/2014 | US20140046018 Biodegradable polymer - bioactive moiety conjugates |
| 02/13/2014 | US20140045951 Synthetic vitreous material |
| 02/13/2014 | US20140045950 Drug delivery vehicle |
| 02/13/2014 | US20140045945 Intracameral sustained release therapeutic agent implants |
| 02/13/2014 | US20140045942 Topical composition |
| 02/13/2014 | US20140045940 Oil body extraction and uses |
| 02/13/2014 | US20140045913 Lipid nano particles comprising combination of cationic lipid |
| 02/13/2014 | US20140045878 Matrix for sustained, invariant and independent release of active compounds |
| 02/13/2014 | US20140045877 Pharmaceutical preparation containing oxycodone and naloxone |
| 02/13/2014 | US20140045797 Bisphosphonate-Prostatic Acid Phosphatase Inhibitor Conjugates To Treat Prostate Cancer Bone Metastasis |
| 02/13/2014 | US20140045794 Phosphonate Compounds |
| 02/13/2014 | US20140045792 Intravaginal ring comprising polyurethane composition for drug delivery |
| 02/13/2014 | US20140045770 Oligomer-protease inhibitor conjugates |
| 02/13/2014 | US20140045753 Coupling of polypeptides at the c-terminus |
| 02/13/2014 | US20140045749 Growth factor complex |
| 02/13/2014 | US20140045698 N-alkyl lactam ethers, and compositions and uses thereof |
| 02/13/2014 | US20140045695 Continuous Fiber Layer Comprising an Active Substance on the Basis of Bio-polymers, the Use Thereof, and Method for the Production Thereof |
| 02/13/2014 | US20140044794 Drug Delivery Particle and Method for Producing the Same |
| 02/13/2014 | US20140044788 Solid Oral Formulations of a Pyridopyrimidinone |
| 02/13/2014 | US20140044787 Controlled release pharmaceutical compositions |
| 02/13/2014 | US20140044786 Once-weekly oral administration of aripiprazole |
| 02/13/2014 | US20140044779 Liquid Carrier for Oral Delivery of a Pharmacologically Active Agent |
| 02/13/2014 | US20140044776 Serpin drugs for treatment of viral infection and method of use thereof |
| 02/13/2014 | US20140044774 Systems and methods for treatment of allergies and other indications |
| 02/13/2014 | US20140044772 Liposomal apparatus and manufacturing methods |
| 02/13/2014 | US20140044755 RNAi PHARMACEUTICAL COMPOSITION FOR SUPPRESSING EXPRESSION OF KRAS GENE |
| 02/13/2014 | US20140044727 Formulations with reduced viscosity |
| 02/13/2014 | US20140044709 Treatment of her2-positive cancer with paclitaxel and trastuzumab-mcc-dm1 |
| 02/13/2014 | US20140044708 Process for lowering the viscosity of highly concentrated protein solutions |
| 02/13/2014 | US20140044669 Cyclodextrin-based polymers for therapeutics delivery |
| 02/13/2014 | US20140044658 Compositions and Methods for Treatment of Infections |
| 02/13/2014 | US20140042654 Fulvestrant nanosphere/microsphere and preparative method and use thereof |
| 02/12/2014 | EP2695621A1 Pharmaceutical preparation |
| 02/12/2014 | EP2695620A1 Caprylate viral deactivation |
| 02/12/2014 | EP2695608A2 Lipid containing formulations |
| 02/12/2014 | EP2695607A1 Method for producing endoplasmic reticulum |
| 02/12/2014 | EP2695605A1 Tranexamic acid composition |
| 02/12/2014 | EP2694562A1 Sugar and peg functionalized polyacetals with controlled ph-dependent degradation |
| 02/12/2014 | EP2694533A2 Method of inducing neutralizing antibodies to human immunodeficiency virus |
| 02/12/2014 | EP2694529A2 Cell penetrating peptides for intracellular delivery of molecules |
| 02/12/2014 | EP2694117A1 Polymalic acid based nanoconjugates for imaging |